These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6777814)

  • 21. Behavioral changes in 6-hydroxydopamine-treated rotation rats after delivery of various neuromodifying agents by means of a stereotactically implanted pellet to the brain.
    Yoshida M; Torigoe R; Ohtsuru K; Kuramoto S
    Stereotact Funct Neurosurg; 1990; 54-55():342-6. PubMed ID: 2127860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum.
    Traub M; Wagner HR; Hassan M; Jackson-Lewis V; Fahn S
    Eur J Pharmacol; 1985 Nov; 118(1-2):147-54. PubMed ID: 3936723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apomorphine-induced behaviour during the oestrous cycle of the rat.
    Kazandjian A; Spyraki C; Sfikakis A; Varonos DD
    Neuropharmacology; 1987 Aug; 26(8):1037-45. PubMed ID: 3658116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of agonists and antagonists of D1 and D2 dopamine receptors on self-stimulation of the medial prefrontal cortex in the rat.
    Ferrer JM; Sanguinetti AM; Vives F; Mora F
    Pharmacol Biochem Behav; 1983 Aug; 19(2):211-7. PubMed ID: 6138775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence.
    Crawley JN; Stivers JA; Blumstein LK; Paul SM
    J Neurosci; 1985 Aug; 5(8):1972-83. PubMed ID: 4040554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antagonism between L-DOPA and apomorphine in their effects on rat behavior].
    Allikmets LKh; Zharkovskiĭ Am; Vasar EE
    Biull Eksp Biol Med; 1977 Jul; 84(7):51-3. PubMed ID: 560890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral effects of apomorphine during development of rats.
    Brus R; Herman ZS; Jamrozik Z
    Acta Physiol Pol; 1977; 28(3):243-6. PubMed ID: 561515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice.
    Tabar J; Hashizume M; Cook CJ; Beart PM; Jackson DM
    Pharmacol Biochem Behav; 1989 May; 33(1):139-46. PubMed ID: 2789405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential behavioral and biochemical effects of four dopaminergic agonists.
    Gianutsos G; Moore KE
    Psychopharmacology (Berl); 1980; 68(2):139-46. PubMed ID: 6107946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats.
    Kenny AM; Schneider MB; Baden DR; Pfeiffer RF; Murrin LC
    Neurology; 1986 Mar; 36(3):400-4. PubMed ID: 3081831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
    Vasse M; Chagraoui A; Protais P
    Eur J Pharmacol; 1988 Mar; 148(2):221-9. PubMed ID: 2897924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral interactions produced by co-administration of 7-OH-DPAT with cocaine or apomorphine in the rat.
    Khroyan TV; Fuchs RA; Beck AM; Groff RS; Neisewander JL
    Psychopharmacology (Berl); 1999 Mar; 142(4):383-92. PubMed ID: 10229063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of dopamine agonists in mature and immature rats.
    McDevitt JT; Setler PE
    Eur J Pharmacol; 1981 Jun; 72(1):69-75. PubMed ID: 6973482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation by sudden darkness of apomorphine-induced behavioral responses.
    Nasello AG; Sassatani AS; Ferreira FS; Felicio LF; Tieppo CA
    Physiol Behav; 2003 Apr; 78(4-5):521-8. PubMed ID: 12782204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonism.
    Nausieda PA; Weiner WJ; Kanapa DJ; Klawans HL
    Neurology; 1978 Nov; 28(11):1183-8. PubMed ID: 568738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulus and response factors affecting the development of behavioral sensitization to apomorphine.
    Mattingly BA; Koch C; Osborne FH; Gotsick JE
    Psychopharmacology (Berl); 1997 Mar; 130(2):109-16. PubMed ID: 9106907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the difference in the behavioral effects of apomorphine in C57BL/6 and DBA/2 mice.
    Vetulani J; Sansone M; Oliverio A
    Pharmacol Biochem Behav; 1982 Nov; 17(5):967-71. PubMed ID: 6891071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of L-histidine and chlorcyclizine on apomorphine-induced climbing behaviour and methamphetamine stereotypy in mice.
    Joshi VV; Balsara JJ; Jadhav JH; Chandorkar AG
    Eur J Pharmacol; 1981 Feb; 69(4):499-502. PubMed ID: 6113966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Snout contact fixation, climbing and gnawing during apomorphine stereotypy in rats from two substrains.
    Szechtman H; Ornstein K; Teitelbaum P; Golani I
    Eur J Pharmacol; 1982 Jun; 80(4):385-92. PubMed ID: 7201932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioural responsiveness to muscimol and apomorphine 2 months after prolonged treatment with estradiol in rats.
    Cuomo V; Cagiano R; Apud J; Masotto C; Racagni G
    Psychopharmacology (Berl); 1984; 84(2):287-8. PubMed ID: 6438692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.